CAU
EOLS icon

Caxton Associates (UK)’s Evolus EOLS Stock Holding History

Caxton Associates (UK)’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16,029
Closed -$148K – 779
2025
Q2 		$148K Buy
+16,029
New +$164K ﹤0.01% 654

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Caxton Associates (UK)'s EOLS Position: Q3 2025 in Review

Caxton Associates (UK) sold out of Evolus (EOLS) in Q3 2025, closing a stake of 16,029 shares — an estimated $148K sold.

Caxton Associates (UK) first reported a position in EOLS in Q2 2025 and held it in 1 quarter. The position peaked at $148K in Q2 2025. 160 funds tracked by Wall St. Rank hold EOLS as of Q3 2025.

  • Caxton Associates (UK) reported no remaining Evolus position as of Q3 2025 after selling out during the quarter.
  • Caxton Associates (UK) sold 16,029 Evolus shares in Q3 2025, an estimated $148K.
  • Caxton Associates (UK) first reported a position in Evolus in Q2 2025 and held it in 1 quarter.
  • Caxton Associates (UK)'s Evolus position peaked at $148K in Q2 2025.
  • 160 funds tracked by Wall St. Rank held Evolus as of Q3 2025.

Based on Caxton Associates (UK)'s 13F filing for Q3 2025, filed 17 Nov 2025.